Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic Blanc

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Plos One|June 11, 2015
Cortical Thickness in Dementia with Lewy Bodies and Alzheimer's Disease: A Comparison of Prodromal and Dementia StagesFrederic Blanc, Sean J Colloby, Nathalie Philippi, et al.
Liver Cancer|February 28, 2022
Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular CarcinomaLorenza Rimassa, Robin Kate Kelley, Tim Meyer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 5, 2022
Associations among hypertension, dementia biomarkers, and cognition: The MEMENTO cohortJérémie Lespinasse, Geneviève Chêne, Jean-Francois Mangin, et al.
Neuroscience and Biobehavioral Reviews|June 25, 2021
Neuroanatomical and cognitive correlates of visual hallucinations in Parkinson's disease and dementia with Lewy bodies: Voxel-based morphometry and neuropsychological meta-analysisStefania Pezzoli, Raquel Sánchez-Valle, Aleix Solanes, et al.
Frontiers in Psychiatry|October 13, 2023
Potential efficacy of dopaminergic antidepressants in treatment resistant anergic-anhedonic depression results of the chronic anergic-anhedonic depression open trial - CADOTLudovic Christophe Dormegny-Jeanjean, Clément de Billy, Olivier Mainberger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2020
Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular CarcinomaRobin Kate Kelley, Tim Meyer, Lorenza Rimassa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 16, 2018
A signature pattern of cortical atrophy in dementia with Lewy bodies: A study on 333 patients from the European DLB consortiumKetil Oppedal, Daniel Ferreira, Lena Cavallin, et al.
Geroscience|July 17, 2021
Therapeutic prevention of COVID-19 in elderly: a case-control studyFrederic Blanc, Cedric Waechter, Thomas Vogel, et al.
The Lancet. Gastroenterology & Hepatology|June 22, 2026
Addition of ipilimumab to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma (PRODIGE 81-FFCD 2101-TRIPLET HCC): phase 2 results from a randomised, multicentre, open-label, phase 2-3 trialPhilippe Merle, Jean-Frederic Blanc, Karine Le Malicot, et al.
Hepatology (Baltimore, Md.)|July 5, 2014
Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trialMasatoshi Kudo, Guohong Han, Richard S Finn, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Plos One|June 11, 2015
Cortical Thickness in Dementia with Lewy Bodies and Alzheimer's Disease: A Comparison of Prodromal and Dementia StagesFrederic Blanc, Sean J Colloby, Nathalie Philippi, et al.
Liver Cancer|February 28, 2022
Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular CarcinomaLorenza Rimassa, Robin Kate Kelley, Tim Meyer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 5, 2022
Associations among hypertension, dementia biomarkers, and cognition: The MEMENTO cohortJérémie Lespinasse, Geneviève Chêne, Jean-Francois Mangin, et al.
Neuroscience and Biobehavioral Reviews|June 25, 2021
Neuroanatomical and cognitive correlates of visual hallucinations in Parkinson's disease and dementia with Lewy bodies: Voxel-based morphometry and neuropsychological meta-analysisStefania Pezzoli, Raquel Sánchez-Valle, Aleix Solanes, et al.
Frontiers in Psychiatry|October 13, 2023
Potential efficacy of dopaminergic antidepressants in treatment resistant anergic-anhedonic depression results of the chronic anergic-anhedonic depression open trial - CADOTLudovic Christophe Dormegny-Jeanjean, Clément de Billy, Olivier Mainberger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2020
Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular CarcinomaRobin Kate Kelley, Tim Meyer, Lorenza Rimassa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 16, 2018
A signature pattern of cortical atrophy in dementia with Lewy bodies: A study on 333 patients from the European DLB consortiumKetil Oppedal, Daniel Ferreira, Lena Cavallin, et al.
Geroscience|July 17, 2021
Therapeutic prevention of COVID-19 in elderly: a case-control studyFrederic Blanc, Cedric Waechter, Thomas Vogel, et al.
The Lancet. Gastroenterology & Hepatology|June 22, 2026
Addition of ipilimumab to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma (PRODIGE 81-FFCD 2101-TRIPLET HCC): phase 2 results from a randomised, multicentre, open-label, phase 2-3 trialPhilippe Merle, Jean-Frederic Blanc, Karine Le Malicot, et al.
Hepatology (Baltimore, Md.)|July 5, 2014
Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trialMasatoshi Kudo, Guohong Han, Richard S Finn, et al.
Pageof 9